ResMed Dividenden en inkoop
Dividend criteriumcontroles 4/6
ResMed is een dividendbetalend bedrijf met een huidig rendement van 0.87% dat ruimschoots wordt gedekt door de winst. Volgende betalingsdatum is op 12th December, 2024 met een ex-dividenddatum van 7th November, 2024.
Belangrijke informatie
0.9%
Dividendrendement
0.4%
Terugkoop Rendement
| Totaal aandeelhoudersrendement | 1.3% |
| Toekomstig dividendrendement | 1.1% |
| Dividendgroei | -11.2% |
| Volgende betaaldatum dividend | 12 Dec 24 |
| Ex-dividenddatum | 07 Nov 24 |
| Dividend per aandeel | US$2.120 |
| Uitbetalingsratio | 26% |
Recente updates van dividend en inkoop
Recent updates
Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why
Nov 13
We Think ResMed (NYSE:RMD) Can Manage Its Debt With Ease
Nov 01Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Oct 20ResMed Inc.'s (NYSE:RMD) Intrinsic Value Is Potentially 47% Above Its Share Price
Oct 08Why ResMed's Rally Is Just Getting Started
Sep 18ResMed Inc.'s (NYSE:RMD) Earnings Haven't Escaped The Attention Of Investors
Sep 13ResMed (NYSE:RMD) Is Increasing Its Dividend To $0.53
Aug 05Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?
Jul 29Returns On Capital Are A Standout For ResMed (NYSE:RMD)
Jul 15ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
Jul 03An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued
Jul 02ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Het dividend per aandeel van RMD is de afgelopen 10 jaar stabiel gebleven.
Groeiend dividend: De dividendbetalingen van RMD zijn de afgelopen 10 jaar gestegen.
Dividendrendement versus markt
| ResMed Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (RMD) | 0.9% |
| Markt onderkant 25% (US) | 1.4% |
| Markt Top 25% (US) | 4.3% |
| Gemiddelde industrie (Medical Equipment) | 1.7% |
| Analist prognose (RMD) (tot 3 jaar) | 1.1% |
Opmerkelijk dividend: Het dividend van RMD ( 0.87% ) is niet noemenswaardig vergeleken met de onderste 25% van de dividendbetalers op de US markt ( 1.38% ).
Hoog dividend: Het dividend RMD ( 0.87% ) is laag vergeleken met de top 25% van dividendbetalers in de US markt ( 4.32% ).
Winstuitkering aan aandeelhouders
Verdiendekking: Met zijn redelijk lage payout ratio ( 26% ) worden de dividendbetalingen van RMD ruimschoots gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Met zijn lage cash payout ratio ( 23.1% ) worden de dividendbetalingen van RMD goed gedekt door de kasstromen.